EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 299 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,192,000 | -13.7% | 20,113 | -4.2% | 0.03% | 0.0% |
Q3 2018 | $1,381,000 | +31.1% | 20,984 | +0.6% | 0.03% | +26.1% |
Q2 2018 | $1,053,000 | -2.1% | 20,850 | +2.0% | 0.02% | -4.2% |
Q1 2018 | $1,076,000 | +22.3% | 20,433 | +7.9% | 0.02% | +26.3% |
Q4 2017 | $880,000 | -48.2% | 18,945 | -68.7% | 0.02% | -63.5% |
Q2 2016 | $1,700,000 | -54.9% | 60,441 | -41.7% | 0.05% | -56.7% |
Q1 2016 | $3,767,000 | -8.6% | 103,641 | +0.6% | 0.12% | -11.1% |
Q4 2015 | $4,120,000 | +45.3% | 102,986 | +3.5% | 0.14% | +36.4% |
Q3 2015 | $2,835,000 | +57.4% | 99,516 | +82.1% | 0.10% | +73.7% |
Q2 2015 | $1,801,000 | +15.0% | 54,655 | +0.4% | 0.06% | +14.0% |
Q1 2015 | $1,566,000 | +6.5% | 54,463 | +0.9% | 0.05% | +4.2% |
Q4 2014 | $1,470,000 | +23.3% | 53,978 | -3.5% | 0.05% | +14.3% |
Q3 2014 | $1,192,000 | -13.6% | 55,924 | -8.7% | 0.04% | -14.3% |
Q2 2014 | $1,380,000 | -31.5% | 61,279 | -23.2% | 0.05% | -34.7% |
Q1 2014 | $2,015,000 | – | 79,746 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 119,994 | $12,399,000 | 6.09% |
Hillcrest Asset Management LLC | 161,826 | $16,721,000 | 2.96% |
SNYDER CAPITAL MANAGEMENT L P | 664,662 | $68,680,000 | 2.94% |
Copper Rock Capital Partners, LLC | 83,374 | $8,615,000 | 2.91% |
RICE HALL JAMES & ASSOCIATES, LLC | 623,132 | $64,388,000 | 2.60% |
Tygh Capital Management, Inc. | 130,526 | $13,487,000 | 2.56% |
PALISADE CAPITAL MANAGEMENT, LP | 428,875 | $44,316,000 | 1.31% |
BECK CAPITAL MANAGEMENT, LLC | 22,067 | $2,280,000 | 1.29% |
EARNEST PARTNERS LLC | 1,394,794 | $144,124,000 | 1.24% |
DC Investments Management, LLC | 10,945 | $1,131,000 | 1.24% |